MyAverix Finance
F · Healthcare
ASCELIA PHARMA AB (7ZA)
Biotechnology
ASCELIA PHARMA AB (7ZA) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 7ZA
ASCELIA PHARMA AB (7ZA) — FAQ
What is 7ZA's P/E ratio?
The price-to-earnings (P/E) ratio for ASCELIA PHARMA AB (7ZA) is 25.00 (data as of 2026-05-23).
Does ASCELIA PHARMA AB pay a dividend?
Dividend yield is not available in the current snapshot for ASCELIA PHARMA AB (7ZA). Check the MyAverix Finance app for the latest dividend data.
What sector is ASCELIA PHARMA AB in?
ASCELIA PHARMA AB (7ZA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 7ZA listed on?
7ZA is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.